Real-world patterns of dose reduction and early discontinuation of abemaciclib for early-stage, hormone-receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2-) breast cancer ...
The automation waves of the past rewarded companies with the best systems, not the most robots, and AI will be no different.
At the recent Data Center World 2026 in Washington, D.C., one message came through louder than ever: AI infrastructure is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results